| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_75b765b53e6651e9863a3a35e4c1e164 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-16 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-115 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-115 |
| filingDate |
2014-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2017-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1c4d0cdccf3c6bc38c4a7a2caadf0e52
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ff93883c6e03d11d2ae2935a5425c31b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a96eff62b66831b53c53b56c936ec25e |
| publicationDate |
2017-10-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-9783808-B2 |
| titleOfInvention |
Ovarian cancer-specific aptamers and applications thereof |
| abstract |
The present invention provides ovarian cancer-specific aptamers, which are selected in vitro using SELEX and a microfluidic chip system. The aptamers can also bind to different histologically-classified ovarian cancer cells with high affinity accordingly. Therefore, the aptamers of the present invention and the applications thereof can not only be used in detection of ovarian cancer cells but also be applied in recognition of different histologically-classified ovarian cancer cells. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11583692-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11577089-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11027143-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344739-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11344740-B2 |
| priorityDate |
2014-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |